Immuneering (IMRX) Short-term Investments: 2021-2024
Historic Short-term Investments for Immuneering (IMRX) over the last 2 years, with Sep 2024 value amounting to $5.5 million.
- Immuneering's Short-term Investments fell 81.33% to $5.5 million in Q3 2024 from the same period last year, while for Sep 2024 it was $5.5 million, marking a year-over-year decrease of 81.33%. This contributed to the annual value of $26.3 million for FY2023, which is 20.15% down from last year.
- Latest data reveals that Immuneering reported Short-term Investments of $5.5 million as of Q3 2024, which was up 9.24% from $5.0 million recorded in Q1 2024.
- Immuneering's Short-term Investments' 5-year high stood at $74.3 million during Q4 2021, with a 5-year trough of $5.0 million in Q2 2023.
- For the 3-year period, Immuneering's Short-term Investments averaged around $26.1 million, with its median value being $27.7 million (2023).
- Data for Immuneering's Short-term Investments shows a maximum YoY plummeted of 87.63% (in 2023) over the last 5 years.
- Over the past 4 years, Immuneering's Short-term Investments (Quarterly) stood at $74.3 million in 2021, then plummeted by 55.74% to $32.9 million in 2022, then decreased by 20.15% to $26.3 million in 2023, then slumped by 81.33% to $5.5 million in 2024.
- Its last three reported values are $5.5 million in Q3 2024, $5.0 million for Q1 2024, and $26.3 million during Q4 2023.